Publication | Closed Access

Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial

ThrombosisTenecteplase Versus AlteplasePhase 3Ischemic StrokeCardiovascular DiseaseMedicineCerebrovascular DiseaseNeurologyNon-inferiority TrialCerebrovascular InterventionCerebral Blood FlowPublic HealthStrokeNeurovascular DiseaseIschemic SyndromeEmergency MedicineReperfusion Injury